Against the Trend, or Is There a Trend?
Markets d
own, I did a bit more buying. I added some COM.TO to my existing position. There are a number of catalysts in the coming months during 2007, and I believe this selloff is sufficient to generate some buying opportunities for me here. I believe it could easily move back to $14-$15 range with some decent announcements, and it could go up to $20-$25 level if its NDA gets a FDA approved this year.
I also opened a position on ATD_B.TO, which has been coming down lately. The company is doing rather well, with
great ROE, good revenue growth (via acquisitions) and very decent earning growth. Valuation is becoming rather attractive here, and it is a consumer staple company, and probably would do well if the economies hit a soft patch. My initial target is $30 and it could hit $33-$35 if I am lucky.
Positions: Long: COM.TO; ATD_B.TO
own, I did a bit more buying. I added some COM.TO to my existing position. There are a number of catalysts in the coming months during 2007, and I believe this selloff is sufficient to generate some buying opportunities for me here. I believe it could easily move back to $14-$15 range with some decent announcements, and it could go up to $20-$25 level if its NDA gets a FDA approved this year.I also opened a position on ATD_B.TO, which has been coming down lately. The company is doing rather well, with
great ROE, good revenue growth (via acquisitions) and very decent earning growth. Valuation is becoming rather attractive here, and it is a consumer staple company, and probably would do well if the economies hit a soft patch. My initial target is $30 and it could hit $33-$35 if I am lucky.Positions: Long: COM.TO; ATD_B.TO
posted by ZIGZAG at 3/27/2007 09:59:00 PM
0 Comments:
Post a Comment
<< Home